Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Massachusetts General Hospital
National Institutes of Health Clinical Center (CC)
Medical University of South Carolina
Lyell Immunopharma, Inc.
Mayo Clinic
Massachusetts General Hospital
The Second Affiliated Hospital of Fujian Medical University
National Institutes of Health Clinical Center (CC)